Stock INBX INHIBRX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Inhibrx, Inc.

Equities

INBX

US45720L1070

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
16.89 USD -1.86% Intraday chart for Inhibrx, Inc. -50.48% -55.55%
Jun. 04 Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing MT
May. 31 Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing
MT
Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index
CI
Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Global BMI Index
CI
Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P TMI Index
CI
Inhibrx, Inc. Announces Termination of Loan Agreement
CI
Inhibrx, Inc. Announces Management Changes
CI
Sanofi Closes Purchase of US Biotech Company Inhibrx
MT
Sanofi: acquisition of Inhibrx finalized
CF
Inhibrx, Inc. completed the Spin-Off of 92% stake in Inhibrx Biosciences, Inc..
CI
Aventis Inc. completed the acquisition of Inhibrx, Inc. from a group of shareholders.
CI
Inhibrx, Inc.(NasdaqGM:INBX) dropped from NASDAQ Biotechnology Index
CI
Inhibrx Shareholders Approve Sale of INBRX-101 Assets to Sanofi
MT
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
PR
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
PR
Inhibrx : Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - Form 8-K
PU
Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX
BU
Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
PR
TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - HMST, FREE, EVBG, INBX
PR
Inhibrx Shares Fall After Q4 Net Loss Widens
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INBX Stock
  4. News Inhibrx, Inc.